hiv-infection/aids
|
0.100 |
Biomarker
|
disease |
BEFREE |
We performed a systematic search for articles reporting on peer-reviewed, quantitative, English-language observational studies of reporting the association between self sero-status disclosure and good ART adherence in adults living with HIV/AIDS in Ethiopia during published from 2010 to 2015.
|
31208346 |
2019 |
hiv-infection/aids
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Factors Associated with Improved HIV/AIDS Treatment Outcomes: Comparing two Major ART Service Delivery Models in Vietnam.
|
31236748 |
2019 |
hiv-infection/aids
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
From April 2017 to October 2018, 800 persons living with HIV/AIDS in a public HIV clinic in Miami completed an interviewer-administered behavioral and chart-review cross-sectional assessment to examine the prevalence and association of number of syndemics (unstable housing, low education, depression, anxiety, binge drinking, drug use, violence, HIV-related stigma) with poor ART adherence, unsuppressed HIV viral load (≥ 200 copies/mL), and biobehavioral transmission risk (condomless sex in the context of unsuppressed viral load).
|
31392443 |
2019 |
hiv-infection/aids
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Cross-sectional study conducted in the Chantal BIYA International Reference Centre for research on HIV/AIDS prevention and management (CIRCB), Yaoundé, Cameroon; data generated between October 2016 and August 2017 amongst adults, adolescents and children at 12, 24, 36 and ≥ 48 months on ART.
|
31744517 |
2019 |
hiv-infection/aids
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The main aim of the study was to determine the prevalence and associated risk factors of Cryptococcal antigenemia (CrAg) among HIV/AIDS Patients on second-line ART Therapy at Ambo General Hospital and Nekemte Referral Hospital, Western Oromia, Ethiopia.
|
31805085 |
2019 |
hiv-infection/aids
|
0.100 |
Biomarker
|
disease |
BEFREE |
Patient costs incurred by people living with HIV/AIDS prior to ART initiation in primary healthcare facilities in Gauteng, South Africa.
|
30742623 |
2019 |
hiv-infection/aids
|
0.100 |
Biomarker
|
disease |
BEFREE |
Acceptability and feasibility of short message service to improve ART medication adherence among people living with HIV/AIDS receiving antiretroviral treatment at Adama hospital medical college, Central Ethiopia.
|
31638936 |
2019 |
hiv-infection/aids
|
0.100 |
Biomarker
|
disease |
BEFREE |
Speech and language assessments were conducted as part of the Pediatric HIV/AIDS Cohort Study Surveillance Monitoring of ART Toxicities study at ages 3 (N = 208) and 5 (N = 429) years.
|
29278615 |
2018 |
hiv-infection/aids
|
0.100 |
Biomarker
|
disease |
BEFREE |
An institutional based retrospective cohort study were undertaken among 1439 adult people living with HIV/AIDS and attending ART clinic between September 1, 2007 and September 1, 2014 at Karamara Hospital was undertaken.
|
29914400 |
2018 |
hiv-infection/aids
|
0.100 |
Biomarker
|
disease |
BEFREE |
We conducted a cross-sectional examination of the physical and psychological factors related to ART adherence among a sample of 400 women living with HIV/AIDS in rural India.
|
27990577 |
2018 |
hiv-infection/aids
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Continued availability of ART (Anti-Retroviral Therapy) to HIV/AIDS patients, and test reagents for CD4 cell count and viral load determination are important measures to alleviate the suffering of these patients.
|
30558571 |
2018 |
hiv-infection/aids
|
0.100 |
Biomarker
|
disease |
BEFREE |
Since the discovery of the secondary preventive benefits of antiretroviral therapy, national and international governing bodies have called for countries to reach 90% diagnosis, ART engagement and viral suppression among people living with HIV/AIDS.
|
29802550 |
2018 |
hiv-infection/aids
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Cases of mother-to-child-transmission in the Surveillance Monitoring of ART Toxicities Study of Pediatric HIV/AIDS Cohort Study were identified from 2007 to 2015.
|
29742647 |
2018 |
hiv-infection/aids
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The impact of dark chocolate intake on arterial elasticity in individuals with HIV/AIDS undergoing ART: a randomized, double-blind, crossover trial.
|
28513635 |
2017 |
hiv-infection/aids
|
0.100 |
Biomarker
|
disease |
BEFREE |
In 2015, the WHO urged countries to provide ART to all people living with HIV, irrespective of their CD4 cell count, this new recommendation supports the Joint United Nations Programme on HIV/AIDS elimination targets.
|
28134713 |
2017 |
hiv-infection/aids
|
0.100 |
Biomarker
|
disease |
BEFREE |
12,966 individuals received ART from HIV/AIDS sentinel hospitals and 1,919 from DDFs, with linkage to care rates of 80.7% and 79.9%, respectively (P > 0.05).
|
28195204 |
2017 |
hiv-infection/aids
|
0.100 |
Biomarker
|
disease |
BEFREE |
KIULARCO provides a framework for improving the quality of care of people living with HIV in sub-Saharan Africa, to generate relevant information to evaluate ART programmes and to build local capacity to deal with HIV/AIDS.
|
28695551 |
2017 |
hiv-infection/aids
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
According to multivariate analysis, smoking (OR = 2.996, 0.992-9.053), lower CD 4+ T-cell count (OR = 3.288, 1.161-9.311), long duration of HIV-infection (OR = 5.946, 2.221-15.915) and non-use of ART (OR = 7.775, 2.618-23.094) were independent risk factors for TB in people living with HIV/AIDS.
|
28358846 |
2017 |
hiv-infection/aids
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Psychological model of ART adherence behaviors in persons living with HIV/AIDS in Mexico: a structural equation analysis.
|
28876412 |
2017 |
hiv-infection/aids
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
New reports of HIV/AIDS cases to the national public health surveillance system (SIVIGILA) in Colombia have shown that there is a growing community at risk of contracting cryptococcosis throughout the country who do not have access to ART.
|
28591262 |
2017 |
hiv-infection/aids
|
0.100 |
Biomarker
|
disease |
BEFREE |
Currently, treatment of HIV/AIDS still depends on highly active antiretroviral therapy (HAART); however, there is increasing evidence showing the emergence of resistance to antiretroviral drugs in HIV-1 strains, making ART less effective over time.
|
25795166 |
2015 |